Autopsy report · NCT02338466

Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion

“Departure of the principal investigator and lack of succession”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University Hospital Center of Martinique

Sponsor type

University, hospital or other

Conditions

Nervous System Disorders; Cerebral Artery

Interventions

rt-PA; tenecteplase

Participants

0

Trials that died the same way

• Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)
  “Departure of the Principal Investigator” (91% match in meaning)
• "Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
  “Principal Investigator's departure” (89% match in meaning)
• Interest of Virtual Reality for the Management of Hospitalized Pregnant Patients at Risk of Preterm Delivery
  “departure of the principal investigator without replacement” (87% match in meaning)
• Preoxygenation Before Prehospital Tracheal Intubation With NIV Versus Balloon
  “departure without replacement of the principal investigator” (83% match in meaning)
• Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer
  “Resignation of Principal Investigator” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.